Clinical Dialogue: Improving Outcomes in Dyslipidemia: New Guidelines, New Opportunities
PAs have several important roles to play in the management of patients with dyslipidemia. To optimize treatment, PAs must be up to date on the characteristics of currently available lipid-lowering therapies, including their relative efficacy and safety profiles. In addition, PAs must have thorough knowledge of the recommended roles of the various lipid-lowering agents as specified in the most current national evidence-based guidelines. To ensure that patients derive the greatest benefit from treatment, PAs should also be well versed in strategies to support good adherence with therapy.
At the conclusion of this activity, the PA should be better able to:
- Use knowledge of the efficacy and safety profiles of the various lipid-lowering therapies when prescribing therapies to treat dyslipidemia.
- Implement current guidelines for the management of patients with dyslipidemia.
- Recognize factors contributing to nonadherence to dyslipidemia therapy and enact strategies to support good adherence.